Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026)
Nuwellis (NUWE) posted Cash from Investing Activities of -$284000.0 for Q1 2026, down 2466.67% on a QoQ basis from $12000.0 in Q4 2025.
Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Nuwellis' Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$284000.0 for Q1 2026.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$284000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$374000.0 (down 1106.45% YoY) and the FY2025 annual result came in at -$90000.0, down 50.0% from the prior year.
- Cash from Investing Activities was -$284000.0 for Q1 2026 at Nuwellis, down from $12000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $14.8 million in Q4 2022 and bottomed at -$284000.0 in Q1 2026.
- A 5-year average of $914000.0 and a median of -$22500.0 in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 4763.64% — and 2025, when it plunged 712.5%.
- Nuwellis' Cash from Investing Activities stood at $14.8 million in 2022, then sank by 99.76% to $36000.0 in 2023, then slumped by 163.89% to -$23000.0 in 2024, then soared by 152.17% to $12000.0 in 2025, then tumbled by 2466.67% to -$284000.0 in 2026.
- Business Quant data shows NUWE's Cash from Investing Activities at -$284000.0 in Q1 2026, $12000.0 in Q4 2025, and -$98000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Nuwellis | 117,386.28 | -1.97 Mn | 1.68 Mn | -284,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -284,000.00 |
| Mar 31, 2026 | -284,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | -121,000.00 |
| Sep 30, 2023 | -121,000.00 |